logo
Select company
Select metric
-42.49%EBIT Margin
VS
Market
18
Sector
48
Industry
74
History
80
$ 10.01Close
$ 9.41 - $ 18.35 52-Week Range
Ticker Information

Ticker

SPRY

Company Name

ARS PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARS PHARMACEUTICALS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SPRY - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -47.73M-42.49%$ 112.34M
3/31/2025$ -15.36M-15.82%$ 97.12M
12/31/2024$ 8.29M9.29%$ 89.15M
9/30/2024$ -49.1M-1912.15%$ 2.57M
6/30/2024$ -44.84M-8968.4%$ 500K
3/31/2024$ -49.7M-496960%$ 10K
12/31/2023$ -54.37M-181216.67%$ 30K
9/30/2023$ -19.95M-1482.54%$ 1.35M
6/30/2023$ -22.95M-1705.27%$ 1.35M
3/31/2023$ -25.01M-1872.16%$ 1.34M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARS PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, ARS PHARMACEUTICALS INC's average EBIT % has been -63345.6%.
  • The median EBIT % for ARS PHARMACEUTICALS INC during this period was -1872.16%
  • ARS PHARMACEUTICALS INC reached its highest EBIT % over the past 5 years at 9.29%.
  • The lowest EBIT % recorded by ARS PHARMACEUTICALS INC in the same timeframe -496960%

ARS PHARMACEUTICALS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
WVE : WAVE LIFE SCIENCES LTD -138.24%ZYME : ZYMEWORKS INC -54.88%NAGE : NIAGEN BIOSCIENCE INC 15.76%CRMD : CORMEDIX INC 42.57%PHAT : PHATHOM PHARMACEUTICALS INC -225.79%URGN : UROGEN PHARMA LTD -144.32%GYRE : GYRE THERAPEUTICS INC 6.85%BEAM : BEAM THERAPEUTICS INC -661.31%ANAB : ANAPTYSBIO INC -107.59%NRIX : NURIX THERAPEUTICS INC -291.58%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for ARS PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -23.97M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

SPRY - EBIT Margin, Last 5 years

-496960%

Minimum

Mar 31, 2024

9.29%

Maximum

Dec 31, 2024

-63345.6%

Average

-1872.16%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%